首页 > 抗体蛋白 > 抗体
Biotin anti-mouse CD8a Antibody
产品名称:
Biotin anti-mouse CD8a Antibody
产品类别:
抗体
产品编号:
100703
产品应用:
100703
[价格]
规格 价格 库存
50µg ¥ 504 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
Application

FC - Quality tested
IHC - Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References

(PubMed link indicates BioLegend citation)
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  30. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Hu J, et al. 2019. Am J Transl Res. 3.043055556. PubMed
  2. Florentin J, et al. 2022. Front Immunol. 13:882484. PubMed
  3. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  4. Guo F, et al. 2022. Front Immunol. 13:833100. PubMed
  5. Wilfahrt D, et al. 2021. Elife. 10:. PubMed
  6. Zhou L, et al. 2021. Cell Mol Immunol. 18:698. PubMed
  7. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  8. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  9. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  10. Mendes A, et al. 2021. Life Sci Alliance. 4:00. PubMed
  11. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  12. Elsner R, et al. 2015. PLoS Pathog. 10: 1004976. PubMed
  13. Wang L, et al. 2019. Cell Rep. 29:1848. PubMed
  14. Zhu C, et al. 2018. Sci Rep. 5.113194444. PubMed
  15. Gutiérrez-Gutiérrez ?, et al. 2021. EMBO Rep. 22:e52905. PubMed
  16. Donley D, et al. 2016. PLoS One. 11: 0162404. PubMed
  17. Giambra V et al. 2018. Cell stem cell. 23(5):714-726 . PubMed
  18. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  19. Gravano D, et al. 2010. PLoS One. 5:e13528. PubMed
  20. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  21. Pokrovskii M, et al. 2020. EMBO J. 39:e104159. PubMed
  22. Achmus L, et al. 2020. Front Neurol. 11:577971. PubMed
  23. Iturri L, et al. 2021. Immunity. . PubMed
  24. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  25. Hutter K, et al. 2020. Molecular Cell. 78(5):876-889.e6. PubMed
  26. Nagaoka M, et al. 2014. J Immunol. 193:2812. PubMed
  27. Van de Velde L, et al. 2016. Cell Rep. 17:2247-2258. PubMed
  28. Xu X, et al. 2020. J Cell Biol. 219:00:00. PubMed
  29. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  30. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  31. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  32. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  33. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  34. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  35. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  36. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  37. Miyazaki M et al. 2017. Immunity. 46(5):818-834 . PubMed
  38. Khaw YM, et al. 2020. J Neuroinflammation. 17:49. PubMed
  39. He J, et al. 2020. Cell Reports. 29(9):2718-2730.e6.. PubMed
  40. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  41. Shen Z, et al. 2021. iScience. 24:103014. PubMed
  42. Kawakami R, et al. 2021. Immunity. 54(5):947-961.e8. PubMed
  43. Khiew SH, et al. 2020. J Clin Invest. 130:3453. PubMed
  44. K?chl R, et al. 2020. Elife. 9:00. PubMed
  45. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  46. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  47. Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed
  48. Matsumura T et al. 2019. Cell Rep. 27(2):561-571 . PubMed
  49. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  50. Dong S, et al. 2021. Nature. 591:117. PubMed
  51. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  52. Onodera T, et al. 2021. Immunity. 54:2385. PubMed
  53. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  54. Wang F, et al. 2021. Cell. 184(2):422-440.e17. PubMed
  55. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  56. Zhang Z, et al. 2019. Haematologica. 4.339583333. PubMed
  57. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  58. Andersen L, et al. 2020. Cell Reports. 29(13):4447-4459.e6.. PubMed
  59. Kaya B, et al. 2020. Cell Reports. 32(5):107979. PubMed
  60. Au-Yeung BB, et al. 2017. J Immunol. 198:2445. PubMed
  61. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  62. Sevin M, et al. 2018. Nat Commun. 9:1431. PubMed
  63. Aftabizadeh M, et al. 2021. JCI Insight. 6:. PubMed
  64. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  65. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  66. Akkaya B, et al. 2017. J Immunol Methods. 441:67. PubMed
  67. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  68. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  69. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  70. Holm J, et al. 2015. PLoS One. 10:125495. PubMed
  71. Frohner IE, et al. 2020. Cell Rep. 30:3171. PubMed
  72. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  73. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  74. Wu J, et al. 2021. STAR Protoc. 2:101022. PubMed
  75. Sch?nberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  76. Lam KC, et al. 2021. Cell. 184:5338. PubMed
  77. Haniuda K, et al. 2020. Cell Rep. 33:108333. PubMed
  78. Macal M et al. 2018. Immunity. 48(4):730-744 . PubMed
  79. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  80. Ji Y, et al. 2019. Nat Immunol. 1.303472222. PubMed
  81. Baja?a S, et al. 2022. iScience. 25:103732. PubMed
  82. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  83. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  84. He M, et al. 2020. Cell Metabolism. 31(3):580-591. PubMed
  85. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  86. Rai S, et al. 2022. Nat Commun. 13:5346. PubMed
  87. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  88. Zheng C, et al. 2022. Acta Pharm Sin B. 12:3726. PubMed
  89. Riedel SS, et al. 2021. Molecular Cell. 81(11):2332-2348.e9. PubMed
  90. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  91. Hirota K et al. 2018. Immunity. 48(6):1220-1232 . PubMed
  92. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  93. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  94. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  95. Young K, et al. 2021. Cell Stem Cell. . PubMed
  96. Davidson M, et al. 2013. PLoS One. 8:76258. PubMed
  97. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
RRID
AB_312742 (BioLegend Cat. No. 100703) AB_312743 (BioLegend Cat. No. 100704)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8a on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线